Engineered Mesenchymal Stem Cell‐Derived Extracellular Vesicles Scavenge Self‐Antigens for Psoriasis Therapy via Modulating Metabolic and Immunological Disorders (Adv. Sci. 6/2025)

Novel Therapy for Psoriasis In article number 2410067, Xin Zhou, Yunsheng Xu, Danyang Li, and co‐workers present a novel engineered mesenchymal stem cell‐derived extracellular vesicles for treating psoriasis, a condition currently lacks a complete cure. This approach can effectively reduce psoriasis‐specific self‐antigens and modulate both metabolic and immunological disorders, thereby providing new insights for psoriasis therapy. [Image: see text]